← Back to Search

PrEP Promotion Messages for HIV/AIDS

N/A

Recruiting

Led By Cui Yang, PhD

Research Sponsored by Johns Hopkins Bloomberg School of Public Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years and older

Biological male sex at birth

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30-day follow up

Awards & highlights

Study Summary

This trial will test whether neuroimaging can help assess how effective HIV prevention messages are for MSM.

Who is the study for?

This trial is for biological males at birth, HIV negative, who've never taken PrEP, are 18 or older, live in/near Baltimore City, and have been sexually active with men. They must be at risk of HIV (e.g., condomless sex or recent STI). Those who joined the open contest can't participate.Check my eligibility

What is being tested?

The study tests how effective different PrEP promotion messages are for preventing HIV in high-risk men. One set of messages is created through an open contest; another set uses a social marketing approach. Their impact will be evaluated using neuroimaging techniques.See study design

What are the potential side effects?

Since this trial focuses on evaluating promotional messages rather than medical treatments, there aren't direct side effects like those associated with drugs or medical procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I was born male.

Select...

I have never taken PrEP medication.

Select...

I have been sexually active with men in the last 6 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30-day follow up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30-day follow up

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30-day follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

change of neural activity

change of willingness and behavioral intention to take PrEP

Secondary outcome measures

PrEP action and initiation

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Open contest messagesExperimental Treatment1 Intervention

Participants will view the top PrEP-promotion messages developed via an open contest.

Group II: Social marketing messagesActive Control1 Intervention

Participants will view the PrEP-promotion messages developed via social marketing.

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

Johns Hopkins Bloomberg School of Public HealthLead Sponsor

410 Previous Clinical Trials

2,106,870 Total Patients Enrolled

Cui Yang, PhDPrincipal InvestigatorJohns Hopkins Bloomberg School of Public Health

2 Previous Clinical Trials

2,700 Total Patients Enrolled

Media Library

PrEP campaign messages developed via open contest Clinical Trial Eligibility Overview. Trial Name: NCT04166851 — N/A

HIV/AIDS Research Study Groups: Open contest messages, Social marketing messages

HIV/AIDS Clinical Trial 2023: PrEP campaign messages developed via open contest Highlights & Side Effects. Trial Name: NCT04166851 — N/A

PrEP campaign messages developed via open contest 2023 Treatment Timeline for Medical Study. Trial Name: NCT04166851 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently taking enrollees for this experiment?

"Clinical trials data hosted on clinicaltrials.gov reveals that this medical study, which debuted in November 2019, is currently seeking participants. The post was refreshed most recently on October 12th 2022."

Answered by AI

What is the current aggregate of participants in this clinical experiment?

"Affirmative. Clinicaltrials.gov's records indicate that this clinical trial, which was first announced on November 15th 2019, is actively recruiting participants. The study seeks to enrol 60 patients from 1 medical facility."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Using Open Contest and Neuro-influence Experiment to Develop and Evaluate PrEP Promotion Messages for High Risk Men

2019. "Using Open Contest and Neuro-influence Experiment to Develop and Evaluate PrEP Promotion Messages for High Risk Men". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04166851.

All > Aids